Cutler Investment Counsel LLC lifted its stake in shares of JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report) by 4.6% during the 4th quarter, HoldingsChannel.com reports. The firm owned 465,225 shares of the company’s stock after buying an additional 20,480 shares during the period. JPMorgan International Research Enhanced Equity ETF makes up 3.6% of Cutler Investment Counsel LLC’s investment portfolio, making the stock its 5th biggest position. Cutler Investment Counsel LLC’s holdings in JPMorgan International Research Enhanced Equity ETF were worth $34,836,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in JIRE. Goldman Sachs Group Inc. bought a new position in shares of JPMorgan International Research Enhanced Equity ETF in the 1st quarter valued at $1,265,000. Raymond James Financial Inc. increased its stake in shares of JPMorgan International Research Enhanced Equity ETF by 24.2% in the second quarter. Raymond James Financial Inc. now owns 595,665 shares of the company’s stock valued at $42,155,000 after buying an additional 116,007 shares during the period. EP Wealth Advisors LLC bought a new position in shares of JPMorgan International Research Enhanced Equity ETF during the second quarter valued at $17,652,000. IHT Wealth Management LLC bought a new position in JPMorgan International Research Enhanced Equity ETF during the 2nd quarter worth $3,506,000. Finally, MML Investors Services LLC raised its position in shares of JPMorgan International Research Enhanced Equity ETF by 887.6% during the second quarter. MML Investors Services LLC now owns 1,358,561 shares of the company’s stock worth $96,145,000 after acquiring an additional 1,221,003 shares during the last quarter.
JPMorgan International Research Enhanced Equity ETF Stock Performance
Shares of NYSEARCA JIRE opened at $81.45 on Friday. The company has a market capitalization of $10.80 billion, a P/E ratio of 16.04 and a beta of 0.78. JPMorgan International Research Enhanced Equity ETF has a 52-week low of $67.89 and a 52-week high of $82.99. The company’s 50 day moving average price is $79.81 and its 200-day moving average price is $78.10.
JPMorgan International Research Enhanced Equity ETF Company Profile
The JPMorgan International Research Enhanced Equity ETF (JIRE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to stocks of any market capitalization from developed markets, excluding North America. JIRE was launched on Jun 10, 2022 and is managed by JPMorgan Chase.
Further Reading
- Five stocks we like better than JPMorgan International Research Enhanced Equity ETF
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Want to see what other hedge funds are holding JIRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report).
Receive News & Ratings for JPMorgan International Research Enhanced Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan International Research Enhanced Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
